Literature DB >> 18547380

Imaging surveillance of the breast in a patient diagnosed with scleroderma after breast-conserving surgery and radiotherapy.

Melanie Seale1, Wan Koh, Michael Henderson, Roslyn Drummond, Jennifer Cawson.   

Abstract

Collagen vascular disease (CVD), particularly scleroderma, is a contraindication to radiation therapy because of increased risk of fibrosis. We report a patient with early stage breast cancer diagnosed with scleroderma after breast-conserving surgery and radiation. She developed marked breast fibrosis, rendering mammographic, sonographic, and clinical surveillance ineffective. She has subsequently been followed with magnetic resonance imaging (MRI) of the breast. We illustrate this case and review the literature relating to CVD and radiation therapy. MRI may be a suitable surveillance method in this situation.

Entities:  

Mesh:

Year:  2008        PMID: 18547380     DOI: 10.1111/j.1524-4741.2008.00603.x

Source DB:  PubMed          Journal:  Breast J        ISSN: 1075-122X            Impact factor:   2.431


  4 in total

1.  Post-Irradiation Morphea: Case report and review of the literature.

Authors:  Ammar Alhathlool; Rüdiger Hein; Christian Andres; Johannes Ring; Bernadette Eberlein
Journal:  J Dermatol Case Rep       Date:  2012-09-28

2.  Localized morphea--a rare but significant secondary complication following breast cancer radiotherapy. Case report and review of the literature on radiation reaction among patients with scleroderma/morphea.

Authors:  Thomas Herrmann; Claudia Günther; Peter Csere
Journal:  Strahlenther Onkol       Date:  2009-09-12       Impact factor: 3.621

3.  Post-Irradiation Morphea of the Breast in a Patient with Subacute Cutaneous Lupus Erythematosus: Case Report and a Literature Review.

Authors:  Carole Anouk Zahn; Laurence Feldmeyer; Roland Blum; Carlo Mainetti
Journal:  Case Rep Dermatol       Date:  2022-05-30

4.  Radiation-induced morphea-a rare but severe late effect of adjuvant breast irradiation : Case report and review of the literature.

Authors:  Richard Partl; Peter Regitnig; Gerlinde Tauber; Michaela Pötscher; Vesna Bjelic-Radisic; Karin S Kapp
Journal:  Strahlenther Onkol       Date:  2018-07-16       Impact factor: 3.621

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.